Helicobacter pylori and its effect on innate and adaptive immunity: New insights and vaccination strategies

Expert Review of Gastroenterology and Hepatology

Volumn 4, Issue 6, 2010, Pages 733-744

  Sundquist, Malin ^a   Quiding Järbrink, Marianne ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

antibody response; dendritic cell; gastritis; Helicobacter pylori; neutrophil; regulatory T cell; Th1; Th17; vaccine

Indexed keywords

CD209 ANTIGEN; CHOLERA TOXIN; HELICOBACTER PYLORI VACCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANTIGEN RECOGNITION; B LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; EOSINOPHIL; GASTRITIS; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MAST CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PEYER PATCH; REGULATORY T LYMPHOCYTE; REVIEW; STOMACH CANCER; TH1 CELL; TH17 CELL;

ADAPTIVE IMMUNITY; ANIMALS; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, INNATE;

EID: 78649642706     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.10.71     Document Type: Review

References (169)

1. Figueiredo C, Machado JC, Yamaoka Y. Pathogenesis of Helicobacter pylori infection. Helicobacter 10(Suppl. 1), 14-20 (2005).
2. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for infammation-associated epithelial cancers. Gastroenterology 128(6), 1567-1578 (2005).
3. Makola D, Peura DA, Crowe SE. Helicobacter pylori infection and related gastrointestinal diseases. J. Clin. Gastroenterology 41(6), 548-558 (2007).
4. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134(1), 306-323 (2008).
5. Suerbaum S, Josenhans C. Helicobacter pylori evolution and phenotypic diversifcation in a changing host. Nat. Rev. 5(6), 441-452 (2007).
6. Kang J, Blaser MJ. Bacterial populations as perfect gases: genomic integrity and diversifcation tensions in Helicobacter pylori. Nat. Rev. 4(11), 826-836 (2006).
7. +-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 287(5452), 482-485 (2000).
8. Ilver D, Arnqvist A, Ogren J et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279(5349), 373-377 (1998).
9. Yamaoka Y, Kikuchi S, el-Zimaity HM et al. Importance of Helicobacter pylori oipA in clinical presentation, gastric infammation, and mucosal interleukin 8 production. Gastroenterology 123(2), 414-424 (2002). (Pubitemid 34827185)
10. Mahdavi J, Sonden B, Hurtig M et al. Helicobacter pylori SabA adhesin in persistent infection and chronic infammation. Science 297(5581), 573-578 (2002).
11. Backert S, Fronzes R, Waksman G. VirB2 and VirB5 proteins: specialized adhesins in bacterial type-IV secretion systems? Trends Microbiol. 16(9), 409-413 (2008).
12. Backert S, Tegtmeyer N, Selbach M. The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 15(3), 163-176 (2010).
13. Schmidt HM, Andres S, Nilsson C et al. The cag PAI is intact and functional but HP0521 varies signifcantly in Helicobacter pylori isolates from Malaysia and Singapore. Eur. J. Clin. Microbiol. Infect. Dis. 29(4), 439-451 (2010).
14. Jones KR, Joo YM, Jang S et al. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J. Clin. Microbiol. 47(4), 959-968 (2009).
15. Basso D, Zambon CF, Letley DP et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135(1), 91-99 (2008).
16. Higashi H, Tsutsumi R, Fujita A et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl Acad. Sci. USA 99(22), 14428-14433 (2002).
17. Argent RH, Hale JL, El-Omar EM, Atherton JC. Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and east Asian strains, and infuences on interleukin-8 secretion. J. Med. Microbiol. 57(Pt 9), 1062-1067 (2008).
18. Rhead JL, Letley DP, Mohammadi M et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133(3), 926-936 (2007).
19. Atherton JC, Cao P, Peek RM Jr et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specifc vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270(30), 17771-17777 (1995).
20. Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128(4), 833-848 (2005).
21. Hussein NR, Argent RH, Marx CK et al. Helicobacter pylori dupA is polymorphic, and its active form induces proinfammatory cytokine secretion by mononuclear cells. J. Infect. Dis. 202(2), 261-269 (2010).
22. Moran A P. Lipopolysaccharide in bacterial chronic infection: insights from Helicobacter pylori lipopolysaccharide and lipid A. Int. J. Med. Microbiol. 297(5), 307-319 (2007).
23. D'Elios MM, Amedei A, Cappon A, Del Prete G, de Bernard M. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol. Med. Microbiol. 50(2), 157-164 (2007). (Pubitemid 46918654)
24. Kivi M, Tindberg Y. Helicobacter pylori occurrence and transmission: a family affair? Scand. J. Infect. Dis. 38(6-7), 407-417 (2006).
25. Kivi M, Johansson AL, Reilly M, Tindberg Y. Helicobacter pylori status in family members as risk factors for infection in children. Epidemiol. Infect. 133(4), 645-652 (2005).
26. Goodman KJ, Correa P. Transmission of Helicobacter pylori among siblings. Lancet 355(9201), 358-362 (2000).
27. O'Connor A, Gisbert J, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 14(Suppl. 1), 46-51 (2009).
28. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53(9), 1374-1384 (2004).
29. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect. Dis. 6(11), 699-709 (2006).
30. Bliss CM Jr, Golenbock DT, Keates S, Linevsky JK, Kelly CP. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect. Immun. 66(11), 5357-5363 (1998).
31. Muotiala A, Helander IM, Pyhala L, Kosunen TU, Moran AP. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun. 60(4), 1714-1716 (1992).
32. Ferrero RL. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol. Immunol. 42(8), 879-885 (2005).
33. Andersen-Nissen E, Smith KD, Strobe KL et al. Evasion of toll-like receptor 5 by fagellated bacteria. Proc. Natl Acad. Sci. USA 102(26), 9247-9252 (2005).
34. Gewirtz AT, Yu Y, Krishna US et al. Helicobacter pylori fagellin evades toll-like receptor 5-mediated innate immunity. J. Infect. Dis. 189(10), 1914-1920 (2004).
35. Smith MF Jr, Mitchell A, Li G et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kB activation and chemokine expression by epithelial cells. J. Biol. Chem. 278(35), 32552-32560 (2003).
36. Torok AM, Bouton AH, Goldberg JB. Helicobacter pylori induces interleukin-8 secretion by toll-like receptor 2-and toll-like receptor 5-dependent and-independent pathways. Infect. Immun. 73(3), 1523-1531 (2005).
37. Ishihara S, Rumi MA, Kadowaki Y et al. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J. Immunol. 173(2), 1406-1416 (2004).
38. Rad R, Ballhorn W, Voland P et al. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology 136(7), 2247-2257 (2009).
39. Obonyo M, Sabet M, Cole SP et al Defciencies of myeloid differentiation factor 88, toll-like receptor 2 (TLR2), or TLR4 produce specifc defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect. Immun. 75(5), 2408-2414 (2007).
40. Amedei A, Cappon A, Codolo G et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest. 116(4), 1092-1101 (2006).
41. Rad R, Brenner L, Krug A et al. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 133(1), 150-163, e3 (2007).
42. Viala J, Chaput C, Boneca IG et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5(11), 1166-1174 (2004).
43. Watanabe T, Asano N, Fichtner-Feigl S et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Invest. 120(5), 1645-1662 (2010).
44. Necchi V, Sommi P, Ricci V, Solcia E. In vivo accumulation of Helicobacter pylori products, NOD1, ubiquitinated proteins and proteasome in a novel cytoplasmic structure. PloS ONE 5(3), e9716 (2010).
45. Bergman MP, Engering A, Smits HH et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 200(8), 979-990 (2004).
46. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB. Carbohydrate-specifc signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10(10), 1081-1088 (2009).
47. Bergin PJ, Edebo A, Wen S et al. Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis. Helicobacter 9(3), 201-210 (2004).
48. Dzierzanowska-Fangrat K, Michalkiewicz J, Cielecka-Kuszyk J et al. Enhanced gastric IL-18 mRNA expression in Helicobacter pylori-infected children is associated with macrophage infltration, IL-8, and IL-1 b mRNA expression. Eur. J. Gastroenterol. Hepatol. 20(4), 314-319 (2008).
49. Kusugami K, Ando T, Imada A et al. Mucosal macrophage infammatory protein-1a activity in Helicobacter pylori infection. J. Gastroenterol. Hepatol. 14(1), 20-26 (1999).
50. Sarsfeld P, Jones DB, Wotherspoon AC, Harvard T, Wright DH. A study of accessory cells in the acquired lymphoid tissue of helicobacter gastritis. J. Pathol. 180(1), 18-25 (1996).
51. Whitney AE, Emory TS, Marty AM et al. Increased macrophage infltration of gastric mucosa in Helicobacter pylori-infected children. Dig. Dis. Sci. 45(7), 1337-1342 (2000).
52. Mai UE, Perez-Perez GI, Wahl LM et al. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide- independent mechanism. J. Clin. Invest. 87(3), 894-900 (1991).
53. Gobert AP, Bambou JC, Werts C et al. Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J. Biol. Chem. 279(1), 245-250 (2004).
54. Harris PR, Ernst PB, Kawabata S et al. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J. Infect. Dis. 178(5), 1516-1520 (1998).
55. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483 (2009).
56. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8(12), 958-969 (2008).
57. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 141(1), 39-51 (2010).
58. Lu H, Ouyang W, Huang C. Infammation, a key event in cancer development. Mol. Cancer Res. 4(4), 221-233 (2006).
59. Meira LB, Bugni JM, Green SL et al. DNA damage induced by chronic infammation contributes to colon carcinogenesis in mice. J. Clin. Invest. 118(7), 2516-2525 (2008).
60. Nam KT, Oh SY, Ahn B et al. Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase. Gut 53(9), 1250-1255 (2004).
61. Tatemichi M, Sawa T, Gilibert I et al. Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter. Cancer Lett. 217(2), 197-202 (2005).
62. Leung SY, Yuen ST, Chu KM et al. Expression profling identifes chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology 127(2), 457-469 (2004).
63. Quiding-Järbrink M, Raghavan S, Sundquist M. Enhanced M1 macrophage polarization in human Helicobacter pylori-associated atrophic gastritis and in vaccinated mice. DOI: 10.1371/journal. pone.0015018 (2010) (Epub head of print).
64. Garhart CA, Heinzel FP, Czinn SJ, Nedrud JG. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but g interferon and inducible nitric oxide synthase independent. Infect. Immun. 71(2), 910-921 (2003).
65. Ihrig M, Whary MT, Dangler CA, Fox JG. Gastric helicobacter infection induces a Th2 phenotype but does not elevate serum cholesterol in mice lacking inducible nitric oxide synthase. Infect. Immun. 73(3), 1664-1670 (2005).
66. Kaparakis M, Walduck AK, Price JD et al. Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice. Infect. Immun. 76(5), 2235-2239 (2008).
67. Algood HM, Allen SS, Washington MK et al. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J. Immunol. 183(9), 5837-5846 (2009).
68. Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr, Cover TL. Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol. Med. Microbiol. 51(3), 577-586 (2007).
69. Zu Y, Cassai ND, Sidhu GS. Light microscopic and ultrastructural evidence of in vivo phagocytosis of Helicobacter pylori by neutrophils. Ultrastruct. Pathol. 24(5), 319-323 (2000).
70. -/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J. Immunol. 170(7), 3782-3789 (2003).
71. DeLyria ES, Redline RW, Blanchard TG. Vaccination of mice against H. pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136(1), 247-256 (2009).
72. Velin D, Bachmann D, Bouzourene H, Michetti P. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 129(1), 142-155 (2005).
73. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10(6), 440-452 (2010).
74. Nakajima S, Krishnan B, Ota H et al. Mast cell involvement in gastritis with or without Helicobacter pylori infection. Gastroenterology 113(3), 746-754 (1997).
75. Ding H, Nedrud JG, Wershil B et al. Partial protection against Helicobacter pylori in the absence of mast cells in mice. Infect. Immun. 77(12), 5543-5550 (2009).
76. -/- mice is dependent on CD4+ T cells but not on mast cells. Helicobacter 13(5), 361-369 (2008).
77. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381(6577), 75-77 (1996).
78. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil infux and bacterial clearance at sites of infection through TNF-α. Nature 381(6577), 77-80 (1996).
79. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig. Dis. Sci. 36(4), 435-440 (1991).
80. Moorchung N, Srivastava AN, Gupta NK et al. The role of mast cells and eosinophils in chronic gastritis. Clin. Exp. Med. 6(3), 107-114 (2006).
81. Piazuelo MB, Camargo MC, Mera RM et al. Eosinophils and mast cells in chronic gastritis: possible implications in carcinogenesis. Hum. Pathol. 39(9), 1360-1369 (2008).
82. Guiney DG, Hasegawa P, Cole SP. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect. Immun. 71(7), 4163-4166 (2003).
83. Hafsi N, Voland P, Schwendy S et al. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J. Immunol. 173(2), 1249-1257 (2004).
84. Hansson M, Lundgren A, Elgbratt K et al. Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3b) after exposure to Helicobacter pylori. Microbes Infect. 8(3), 841-850 (2006).
85. Kranzer K, Eckhardt A, Aigner M et al. Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect. Immun. 72(8), 4416-4423 (2004).
86. Mitchell P, Germain C, Fiori PL et al. Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect. Immun. 75(2), 810-819 (2007).
87. Bimczok D, Clements RH, Waites KB et al. Human primary gastric dendritic cells induce a Th1 response to H. pylori. Mucosal Immunol. 3(3), 260-269 (2010).
88. Kao JY, Zhang M, Miller MJ et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138(3), 1046-1054 (2010).
89. Zhang M, Berndt BE, Eaton KA et al. Helicobacter pylori-pulsed dendritic cells induce H. pylori-specifc immunity in mice. Helicobacter 13(3), 200-208 (2008).
90. Wang YH, Gorvel JP, Chu Y T, Wu JJ, Lei HY. Helicobacter pylori impairs murine dendritic cell responses to infection. PloS ONE 5(5), e10844 (2010).
91. Kao JY, Rathinavelu S, Eaton KA et al. Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense. Am. J. Physiol. Gastrointest. Liver Physiol. 291(1), G73-G81 (2006).
92. Necchi V, Manca R, Ricci V, Solcia E. Evidence for transepithelial dendritic cells in human H. pylori active gastritis. Helicobacter 14(3), 208-222 (2009).
93. Nishi T, Okazaki K, Kawasaki K et al. Involvement of myeloid dendritic cells in the development of gastric secondary lymphoid follicles in Helicobacter pylori-infected neonatally thymectomized BALB/c mice. Infect. Immun. 71(4), 2153-2162 (2003).
94. Krauss-Etschmann S, Gruber R, Plikat K et al. Increase of antigen-presenting cells in the gastric mucosa of Helicobacter pylori-infected children. Helicobacter 10(3), 214-222 (2005).
95. + T lymphocytes. Infect. Immun. 78(2), 845-853 (2010).
96. Angel CE, Chen CJ, Horlacher OC et al. Distinctive localization of antigen-presenting cells in human lymph nodes. Blood 113(6), 1257-1267 (2009).
97. + macrophages in intestinal lamina propria exhibit potent antigen-presenting ability. J. Immunol. 183(3), 1724-1731 (2009).
98. + dermal dendritic cells. Immunity 29(3), 497-510 (2008).
99. Kiriya K, Watanabe N, Nishio A et al. Essential role of Peyer's patches in the development of Helicobacter-induced gastritis. Int. Immunol. 19(4), 435-446 (2007).
100. Nagai S, Mimuro H, Yamada T et al. Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc. Natl Acad. Sci. USA 104(21), 8971-8976 (2007).
101. Ruddle NH, Akirav EM. Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response. J. Immunol. 183(4), 2205-2212 (2009).
102. + regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice. Infect. Immun. 74(6), 3519-3529 (2006).
103. Bamford KB, Fan X, Crowe SE et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114(3), 482-492 (1998).
104. Haeberle HA, Kubin M, Bamford KB et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with g interferon-producing T cells in the human gastric mucosa. Infect. Immun. 65(10), 4229-4235 (1997).
105. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun. 66(12), 5964-5971 (1998).
106. Yamauchi K, Choi IJ, Lu H et al. Regulation of IL-18 in Helicobacter pylori infection. J. Immunol 180(2), 1207-1216 (2008).
107. D'Elios MM, Manghetti M, de Carli M et al. T helper 1 effector cells specifc for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158(2), 962-967 (1997).
108. Smythies LE, Waites KB, Lindsey JR et al. Helicobacter pylori-induced mucosal infammation is Th1 mediated and exacerbated in IL-4, but not IFN-y, gene-defcient mice. J. Immunol. 165(2), 1022-1029 (2000).
109. Akhiani AA, Pappo J, Kabok Z et al Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol. 169(12), 6977-6984 (2002).
110. + T cell-mediated IFN-y response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J. Immunol. 182(11), 7085-7101 (2009).
111. Eaton KA, Mefford M, Thevenot T The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol. 166(12), 7456-7461 (2001).
112. Eaton KA, Mefford ME. Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice. Infect. Immun. 69(2), 1025-1031 (2001).
113. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113(6), 1848-1857 (1997).
114. Shi Y, Liu XF, Zhuang Y et al Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, beneft bacterial growth, and contribute to pathology in mice. J. Immunol. 184(9), 5121-5129 (2010).
115. Luzza F, Parrello T, Monteleone G et al Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 165(9), 5332-5337 (2000).
116. Shiomi S, Toriie A, Imamura S et al. IL-17 is involved in Helicobacter pylori-induced gastric infammatory responses in a mouse model. Helicobacter 13(6), 518-524 (2008).
117. Velin D, Favre L, Bernasconi E et al Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 136(7), 2237-2246 e2231 (2009).
118. + regulatory T cells in immunological tolerance to self and non-self Nat. Immunol. 6(4), 345-352 (2005).
119. high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun. 73(1), 523-531 (2005).
120. Enarsson K, Lundgren A, Kindlund B et al. Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin. Immunol. 121(3), 358-368 (2006).
121. +) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-β1. Helicobacter 13(4), 295-303 (2008).
122. +) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients. Helicobacter 14(3), 192-201 (2009).
123. + T cells regulate gastric infammation and Helicobacter pylori colonization in vivo. Gastroenterology 131(2), 525-537 (2006).
124. high regulatory T cells suppress memory T-cell responses to H pylori in infected individuals. Infect. Immun. 71(4), 1755-1762 (2003).
125. + T cell responses in Helicobacter pylori-infected individuals. Clin. Exp. Immunol. 123(1), 81-87 (2001).
126. Fan XJ, Chua A, Shahi CN et al. Gastric T lymphocyte responses to Helicobacter pylori in patients with H. pylori colonisation. Gut 35(10), 1379-1384 (1994).
127. Sharma SA, Miller GG, Perez-Perez GI, Gupta RS, Blaser MJ. Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant. Clin. Exp. Immunol. 97(1), 126-132 (1994).
128. Karttunen R. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori. Clin. Exp. Immunol. 83(3), 396-400 (1991).
129. high regulatory T cells reduce T cell transendothelial migration in cancer patients. Eur. J. Immunol. 37(1), 282-291 (2007).
130. + regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin. Exp. Immunol. 132(3), 393-400 (2003).
131. Robinson K, Kenefeck R, Pidgeon EL et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 57(10), 1375-1385 (2008).
132. Harris PR, Wright SW, Serrano C et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134(2), 491-499 (2008).
133. Jang TJ. The number of Foxp3-positive regulatory T cells is increased in Helicobacter pylori gastritis and gastric cancer. Pathol. Res. Pract. 206(1), 34-38 (2009).
134. Mattsson A, Tinnert A, Hamlet A et al. Specifc antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Clin. Diagn. Lab. Immunol. 5(3), 288-293 (1998).
135. Mattsson A, Quiding-Jarbrink M, Lonroth H et al. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect. Immun. 66(6), 2705-2712 (1998). (Pubitemid 28261773)
136. Rathbone BJ, Wyatt JI, Worsley BW et al. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 27(6), 642-647 (1986).
137. Jones DM, Eldridge J, Fox AJ, Sethi P, Whorwell PJ. Antibody to the gastric campylobacter-like organism ('Campylobacter pyloridis')-clinical correlations and distribution in the normal population. J. Med. Microbiol. 22(1), 57-62 (1986).
138. Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann. Intern. Med. 109(1), 11-17 (1988).
139. Mini R, Bernardini G, Salzano AM et al. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J. Chromatogr. 833(1), 63-79 (2006).
140. Mattsson A, Lonroth H, Quiding-Jarbrink M, Svennerholm AM. Induction of B cell responses in the stomach of Helicobacter pylori-infected subjects after oral cholera vaccination. J. Clin. Invest. 102(1), 51-56 (1998).
141. Quiding-Jarbrink M, Lonroth H, Ahlstedt I, Holmgren J, Svennerholm AM. Human gastric B cell responses can be induced by intestinal immunisation. Gut 49(4), 512-518 (2001).
142. Hansson M, Hermansson M, Svensson H et al. CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells. Infect. Immun. 76(7), 3304-3311 (2008).
143. +-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 115(2), 340-347 (1998).
144. Yamanishi S, Iizumi T, Watanabe E et al. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect. Immun. 74(1), 248-256 (2006).
145. D'Elios MM, Appelmelk BJ, Amedei A, Bergman MP, Del Prete G. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol. Med. 10(7), 316-323 (2004).
146. Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J. Exp. Med. 191(1), 115-128 (2000).
147. Zheng PY, Jones NL. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell. Microbiol 5(1), 25-40 (2003).
148. Gobert AP, McGee DJ, Akhtar M et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl Acad. Sci. USA 98(24), 13844-13849 (2001).
149. Gobert AP, Cheng Y, Wang JY et al. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J. Immunol. 168(9), 4692-4700 (2002).
150. Das S, Suarez G, Beswick EJ et al Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J. Immunol. 176(5), 3000-3009 (2006).
151. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301(5636), 1099-1102 (2003).
152. Schmees C, Prinz C, Treptau T et al. Inhibition of T-cell proliferation by Helicobacter pylori y-glutamyl transpeptidase. Gastroenterology 132(5), 1820-1833 (2007).
153. Molinari M, Salio M, Galli C et al. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187(1), 135-140 (1998).
154. Azevedo NF, Huntington J, Goodman KJ. The epidemiology of Helicobacter pylori and public health implications. Helicobacter 14(Suppl. 1), 1-7 (2009).
155. Rupnow MF, Owens DK, Shachter R, Parsonnet J. Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology. Helicobacter 4(4), 272-280 (1999).
156. Del Giudice G, Malfertheiner P, Rappuoli R. Development of vaccines against Helicobacter pylori. Expert Rev. Vaccines 8(8), 1037-1049 (2009).
157. Rizos K, Lattemann CT, Bumann D, Meyer TF, Aebischer T. Autodisplay: effcacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains. Infect. Immun. 71(11), 6320-6328 (2003).
158. Smythies LE, Novak MJ, Waites KB et al. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection. Vaccine 23(7), 901-909 (2005).
159. Dzwonek A, Mikula M, Woszczynski M, Hennig E, Ostrowski J. Protective effect of vaccination with DNA of the H. pylori genomic library in experimentally infected mice. Cell. Mol. Biol. Lett. 9(3), 483-495 (2004).
160. Ermak TH, Giannasca PJ, Nichols R et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188(12), 2277-2288 (1998).
161. Pappo J, Torrey D, Castriotta L et al. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect. Immun. 67(1), 337-341 (1999).
162. Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P. Gastric mucosal a(4)b(7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. Gastroenterology 119(1), 109-118 (2000).
163. Akhiani AA, Schon K, Lycke N. Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-defcient mice. J. Immunol. 173(5), 3348-3356 (2004).
164. Panthel K, Faller G, Haas R. Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity. Infect. Immun. 71(2), 794-800 (2003).
165. De Rosa V, Procaccini C, Cali G et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 6(2), 241-255 (2007).
166. Wehrens A, Aebischer T, Meyer TF, Walduck AK. Leptin receptor signaling is required for vaccine-induced protection against Helicobacter pylori. Helicobacter 13(2), 94-102 (2008).
167. Aebischer T, Bumann D, Epple HJ et al. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty2 1a-based salmonella vaccines. Gut 57(8), 1065-1072 (2008).
168. Malfertheiner P, Schultze V, Rosenkranz B et al. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a Phase I study. Gastroenterology 135(3), 787-795 (2008).
169. Reibman J, Marmor M, Filner J et al Asthma is inversely associated with Helicobacter pylori status in an urban population. PloS ONE, 3(12), e4060 (2008).